ACCF/AHA TASK FORCE MEMBERS

By D. Goff, D. Lloyd‐Jones, S. Coady, Jennifer G. Robinson, F. J. S. Schwartz, R. Gibbons, Susan T. Shero, P. Greenland, D. Lackland, P. Sorlie and 2 more. 2013

770 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

[2017 ESC/EACTS Guidelines for the management of valvular heart disease]. (2017, background): “Underlying uncertainties on the risk–benefit ratio of the combination of VKA with aspirin account for discrepancies between different recommendations.(192,193) When added to anticoagulation, antiplatelet agents decrease thromboembolic risk but increase the risk of major bleeding.”
Moving beyond regression techniques in cardiovascular risk prediction: applying machine learning to address analytic challenges (2016, methodology): “Models for risk of cardiovascular disease are used to identify patients for statin therapy(1) and choose anticoagulation strategies for atrial fibrillation.(2) Traditional approaches for developing prediction tools have used regression-based models, such as a logistic model to predict 30-day mortali”
2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association. (2012, result): “This is in line with the 2011 focused update from the ACCF/ AHA and HRS, and the 2012 expert consensus statement on catheter and surgical ablation, co-authored by the EHRA.6,186 For patients with highly symptomatic paroxysmal AF with a low-risk profile for catheter ablation, primary catheter ablatio”